Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats

Brain Research

Volumn 868, Issue 1, 2000, Pages 95-104

  Disshon, Kimberly A ^a   Dluzen, Dean E ^a  

^a Northeast Ohio Medical University   (United States)

Author keywords

Estradiol; Microdialysis; MPTP; Neuroprotection; Neurotoxicity; Nigrostriatal; Park inson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ESTRADIOL; ESTROGEN;

ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; ESTROGEN THERAPY; FEMALE; MALE; MICRODIALYSIS; NEUROLOGIC DISEASE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; ESTROGENS; EXTRACELLULAR SPACE; FEMALE; HERBICIDES; MALE; MICRODIALYSIS; NERVE DEGENERATION; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 0034674753     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02329-5     Document Type: Article

References (52)

1. Ali S.F., Freyaldenhoven T. MPTP - A model of parkinson's disease. Bondy S.C. Chemicals and Neurodegenerative Disease. 1999;162-188 Prominent Press, Scottsdale.
2. Attali G., Weizman A., Gil-Ad I., Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 756:1997;153-159.
3. Barber P.V., Arnold A.G., Evans G. Recurrent hormone dependent chorea: effects of oestrogens and progestogens. Clin. Endo. 5:1976;291-293.
4. Becker J.B. Direct effect of 17β-estradiol on striatum: sex differences in dopamine release. Synapse. 5:1990;157-164.
5. Bedard P.J., Di Paolo T., Langelier P., Poyet P., Labrie F. Behavioral and biochemical evidence of an effect of estradiol on striatal dopamine receptors. Fuxe K., Gustafsson J.-A., Welterberg L. Steroid Hormone Regulation of the Brain. 1981;331-339 Pergamon Press, Oxford.
6. Bedard P.J., Langelier P., Villeneuve A. Oestrogens and extrapyramidal system. Lancet. 2:1977;1367-1368.
7. Brooks W.J., Jarvis M.F., Wagner G.C. Influence of sex, age, and strain on MPTP-induced neurotoxicity. Res. Comm. Stubst. Abuse. 10:1989;181-184.
8. Butcher R.L., Collins W.E., Fugo N.W. Plasma concentration of LH, FSH, Prolactin, Progesterone and Estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology. 94:1974;1704-1708.
9. + on endogenous dopamine release from the rat corpus striatum superfused in vitro. Brain Res. 368:1986;134-140.
10. + enhances potassium-evoked striatal dopamine release through a w-conotoxin-insensitive, tetrodotoxin and nimodipine-sensitive calcium-dependent mechanism. Ann. NY Acad. Sci. 635:1991;393-396.
11. +. Free Rad. Biol. Med. 13:1992;581-583.
12. Chiueh C.C., Maiyake H., Peng M.T. Role of dopamine auto-oxidation, hydroxyl radical generation and calcium overload in underlying mechanisms involved in MPTP-induced Parkinsonism. Adv. Neurol. 60:1993;251-258.
13. Chiueh C.C., Wu R.-M., Mohanuakumar K.P., Sternberger L.M., Krishna G., Obata T., Murphy D.L. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. NY Acad. Sci. 738:1994;25-36.
14. +: Possible action at the dopamine transporter. Br. J. Pharmacol. 114:1995;315-322.
15. J. DeGroot, The rat forebrain in stereotaxic coordinates, in: Verhandelingen der Koninkijke Nederlandse Akademie van Wetenschappen, Afd. Natuurkunde, N.V. Noord-Hallandsche Uitg. Mij., Amsterdam, 1959.
16. Di Paolo T., Rouillard C., Bedard P. 17β-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol. 117:1985;197-203.
17. Disshon K.A., Boja J.W., Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17β-estradiol. Eur. J. Pharmacol. 345:1998;207-211.
18. Disshon K.A., Dluzen D.E. Estrogen as a neuromodulator of MPTP-induced neurotoxicity: Effects upon striatal dopamine and release. Brain Res. 764:1997;9-16.
19. Disshon K.A., Dluzen D.E. Use of in vitro superfusion to assess the dynamics of striatal dopamine transporters: Influence of estrogen. Brain Res. 842:1999;399-407.
20. Dluzen D.E. The effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/Bl mice. Brain Res. 715:1996;113-118.
21. Dluzen D.E. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 767:1997;340-344.
22. D.E. Dluzen, Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system, J. Neurocytol. (2000), in press.
23. Dluzen D.E., Disshon K.A., McDermott J. Estrogen as a modulator of striatal dopaminergic neurotoxicity. Marwah J., Teitelbaum H. Recent Advances in Neurodegenerative Disorders. 1998;149-192 Prominent Press, Scottsdale, AZ.
24. D.E. Dluzen, J.L. McDermott, Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: Implications for parkinson's disease, J. Gender-Specific Med. (2000), in press.
25. D.E. Dluzen, J.L. McDermott, Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system, Ann. NY Acad. Sci. (2000), in press.
26. Dluzen D.E., McDermott J., Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release. J. Neurochem. 66:1996;658-666.
27. Dluzen D.E., McDermott J.L., Liu B. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/Bl mice. Neurotox. Teratol. 18:1996;603-606.
28. Dluzen D.E., Ramirez V.D. In vivo changes in responsiveness of the caudate nucleus to L-Dopa infusion as a function of the estrous cycle. Brain Res. 536:1990;163-168.
29. Figlewicz D.P., Patterson T.A., Zavosh A., Brot M., Roitman M., Szot P. Neurotransmitter transporters: Target for endocrine regulation. Horm. Metab. Res. 31:1999;335-339.
30. Freyaldenhoven T.E., Cadet J.L., Ali S.F. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 are gender-dependent. Brain Res. 735:1996;232-238.
31. Gamboa E.Y., Issacs G., Harter D.H. Chorea associated with oral contraceptive therapy. Arch. Neurol. 25:1971;112-114.
32. M. Grandbois, B. Tanguay, T. Di Paolo, Estradiol and dehydroepiandrosterone but not dihydrotestosterone protect against MPTP-induced dopamine depletion in mice, Soc. Neurosci. Abst. # 639.6, 25 (1999) 1595.
33. Hruska R.E. Elevation of striatal dopamine receptors by estrogen: Dose and time studies. J. Neurochem. 47:1986;1908-1915.
34. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. 82:1985;2173-2177.
35. 3H]17β-estradiol in rats: Male-specific 15a- and male-selective 16a-hydroxylation and female-selective catechol formation. J. Steroid Biochem. Mol. Biol. 42:1992;65-76.
36. M. Maus, J. Premont, J. Glowinski, In vitro effects of 17β-estradiol on the sensitivity of receptors coupled to adenylate cyclase on striatal neurons in primary culture, in: Steroids and neuronal activity, CIBA Foundation Symposium 153, New York: Wiley Press (1990) pp. 145-155.
37. McDermott J.L., Liu B., Dluzen D.E. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp. Neurol. 125:1994;306-311.
38. Mermelstein P.G., Becker J.B., Surmeier D.J. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16:1996;595-604.
39. Miller D.B., Ali S.F., O'Callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. NY Acad. Sci. 844:1998;153-165.
40. Morissette M., Di Paolo T. Effect of chronic estradiol and progesterone treatment of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60:1993;1876-1883.
41. +. J. Neural Transm. 89:1992;139-145.
42. Obata T., Yamanaka Y., Chiueh C.C. In vivo release of dopamine by perfusion of 1-methyl-4-phenylpyridinium ion in the striatum with a microdialysis technique. Jpn. J. Pharmacol. 60:1992;311-313.
43. +) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a microdialysis technique. J. Neural Transm. 70:1987;241-250.
44. Pasqualini C., Olivier V., Guibert B., Frain O., Leviel V. Acute stimulatory effect of estradiol on striatal dopamine synthesis. J. Neurochem. 65:1995;1651-1657.
45. Ramirez V.D., Kim K., Dluzen D.E. Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: In vitro and in vivo studies. Recent Prog. Horm. Res. 41:1985;421-472.
46. Ricaurte G.A., Langston J.W., DeLanney L.E., Irwin I., Brooks J.D. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neurosci. Lett. 59:1985;259-264.
47. +-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis. J. Pharmacol. Exp. Ther. 245:1988;858-866.
48. Thompson T.L. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res. 834:1999;164-167.
49. Unzeta M., Baron S., Perez V., Ambrosio S., Mahy N. Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B. Neurosci. Lett. 176:1994;235-238.
50. Van Hartesveldt C., Joyce J.N. Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10:1986;1-14.
51. Wagner G.C., Tekirian T.L., Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. 93:1993;67-70.
52. Yu Y.-L., Wagner G.C. Influence of gonadal steroid hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. [P-D-Sect]. 8:1994;215-221.